Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quality Improvement Intervention for Reducing Acute Treatment Times in Ischemic Stroke: A Cluster Randomized Clinical Trial.
Hansen D, den Hartog SJ, van Leeuwen N, Boiten J, Dinkelaar W, van Doormaal PJ, Eijkenaar F, Emmer BJ, van Es ACGM, Flach HZ, Gons R, den Hertog MH, Imani F, Janssen PM, Kortman H, Kruyt ND, Kuhrij LS, van der Leij C, Lo THR, van der Lugt A, Lycklama À Nijeholt G, Martens JMM, Nederkoorn PJ, Piet J, Remmers MJM, Roos YBWEM, Silvis SM, Stolze LJ, Stomp W, van Tuijl JH, Truijman MTB, Vermeer SE, van Walderveen MAA, van den Wijngaard IR, Van der Worp HB, Yo L, Dippel DWJ, Lingsma HF, Roozenbeek B; PERFEQTOS Investigators. Hansen D, et al. Among authors: gons r. JAMA Neurol. 2024 Dec 16. doi: 10.1001/jamaneurol.2024.4304. Online ahead of print. JAMA Neurol. 2024. PMID: 39680396
Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design.
Chalos V, A van de Graaf R, Roozenbeek B, C G M van Es A, M den Hertog H, Staals J, van Dijk L, F M Jenniskens S, J van Oostenbrugge R, H van Zwam W, B W E M Roos Y, B L M Majoie C, F Lingsma H, van der Lugt A, W J Dippel D; MR CLEAN-MED investigators. Chalos V, et al. Trials. 2020 Jul 14;21(1):644. doi: 10.1186/s13063-020-04514-9. Trials. 2020. PMID: 32665035 Free PMC article.
A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke.
LeCouffe NE, Kappelhof M, Treurniet KM, Rinkel LA, Bruggeman AE, Berkhemer OA, Wolff L, van Voorst H, Tolhuisen ML, Dippel DWJ, van der Lugt A, van Es ACGM, Boiten J, Lycklama À Nijeholt GJ, Keizer K, Gons RAR, Yo LSF, van Oostenbrugge RJ, van Zwam WH, Roozenbeek B, van der Worp HB, Lo RTH, van den Wijngaard IR, de Ridder IR, Costalat V, Arquizan C, Lemmens R, Demeestere J, Hofmeijer J, Martens JM, Schonewille WJ, Vos JA, Uyttenboogaart M, Bokkers RPH, van Tuijl JH, Kortman H, Schreuder FHBM, Boogaarts HD, de Laat KF, van Dijk LC, den Hertog HM, van Hasselt BAAM, Brouwers PJAM, Bulut T, Remmers MJM, van Norden A, Imani F, Rozeman AD, Elgersma OEH, Desfontaines P, Brisbois D, Samson Y, Clarençon F, Krietemeijer GM, Postma AA, van Doormaal PJ, van den Berg R, van der Hoorn A, Beenen LFM, Nieboer D, Lingsma HF, Emmer BJ, Coutinho JM, Majoie CBLM, Roos YBWEM; MR CLEAN–NO IV Investigators. LeCouffe NE, et al. Among authors: gons rar. N Engl J Med. 2021 Nov 11;385(20):1833-1844. doi: 10.1056/NEJMoa2107727. N Engl J Med. 2021. PMID: 34758251 Clinical Trial.
Costs and health effects of CT perfusion-based selection for endovascular thrombectomy within 6 hours of stroke onset: a model-based health economic evaluation.
van Voorst H, Hoving JW, Koopman MS, Daems JD, Peerlings D, Buskens E, Lingsma H, Marquering HA, de Jong HWAM, Berkhemer OA, van Zwam WH, van Walderveen MAA, van den Wijngaard IR, Dippel DWJ, Yoo AJ, Campbell B, Kunz WG, Majoie CB, Emmer BJ; CLEOPATRA; MR CLEAN Registry; CONTRAST Consortium Investigators. van Voorst H, et al. J Neurol Neurosurg Psychiatry. 2024 May 14;95(6):515-527. doi: 10.1136/jnnp-2023-331862. J Neurol Neurosurg Psychiatry. 2024. PMID: 38124162
Sex differences in outcomes after endovascular treatment in posterior circulation stroke: results from the MR CLEAN Registry.
Ali M, Dekker L, Ali M, Van Zwet EW, Hofmeijer J, Nederkoorn PJ, Majoie CB, van Es AC, Uyttenboogaart M, van der Meij A, van Walderveen MAA, Visser MC, Dippel DW, Schonewille WJ, van den Wijngaard IR, Kruyt ND, Wermer MJH; MR CLEAN Registry Investigators. Ali M, et al. J Neurointerv Surg. 2024 Dec 26;17(e1):e74-e82. doi: 10.1136/jnis-2023-021086. J Neurointerv Surg. 2024. PMID: 38171605 Clinical Trial.
Effect of Intravenous Alteplase Treatment on First-Line Stent Retriever Versus Aspiration Alone During Endovascular Treatment.
Rinkel LA, Treurniet KM, Nieboer D, Kappelhof M, LeCouffe NE, Bruggeman AAE, van Zwam WH, Lycklama À Nijeholt GJ, Ghariq E, Uyttenboogaart M, Dippel DWJ, Roos YBWEM, Coutinho JM, Majoie CBLM, Emmer BJ; MR CLEAN-NO IV Investigators. Rinkel LA, et al. Stroke. 2022 Nov;53(11):3278-3288. doi: 10.1161/STROKEAHA.121.038390. Epub 2022 Jul 25. Stroke. 2022. PMID: 35876018 Clinical Trial.
Hemorrhage rates in patients with acute ischemic stroke treated with intravenous alteplase and thrombectomy versus thrombectomy alone.
van Kranendonk KR, Kappelhof M, Bruggeman AAE, Rinkel LA, Treurniet KM, LeCouffe N, Emmer BJ, Coutinho JM, Wolff L, van Zwam WH, van Oostenbrugge RJ, van der Lugt A, Dippel DWJ, Roos YBWEM, Marquering HA, Majoie CBLM; MR CLEAN-NO IV Investigators. van Kranendonk KR, et al. J Neurointerv Surg. 2023 Nov;15(e2):e262-e269. doi: 10.1136/jnis-2022-019569. Epub 2022 Nov 17. J Neurointerv Surg. 2023. PMID: 36396434 Clinical Trial.
Observational Dutch Young Symptomatic StrokE studY (ODYSSEY): study rationale and protocol of a multicentre prospective cohort study.
Arntz RM, van Alebeek ME, Synhaeve NE, Brouwers PJ, van Dijk GW, Gons RA, den Heijer T, de Kort PL, de Laat KF, van Norden AG, Vermeer SE, van der Vlugt MJ, Kessels RP, van Dijk EJ, de Leeuw FE. Arntz RM, et al. BMC Neurol. 2014 Mar 22;14:55. doi: 10.1186/1471-2377-14-55. BMC Neurol. 2014. PMID: 24655479 Free PMC article.
Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window (MR CLEAN-LATE): 2-year follow-up of a phase 3, multicentre, open-label, randomised controlled trial in the Netherlands.
Huijberts I, Pinckaers FME, Olthuis SGH, van Kuijk SMJ, Postma AA, Boogaarts HD, Roos YBWEM, Majoie CBLM, van der Lugt A, Dippel DWJ, van Zwam WH, van Oostenbrugge RJ; MR CLEAN-LATE investigators. Huijberts I, et al. Lancet Neurol. 2024 Sep;23(9):893-900. doi: 10.1016/S1474-4422(24)00228-X. Epub 2024 Jun 20. Lancet Neurol. 2024. PMID: 38909624 Clinical Trial.
43 results